11/06/2015 - 3:08pm

Novira is a company working on curative treatments for chronic hepatitis B. 

11/06/2015 - 1:59pm

The two companies on Friday announced a development and commercialization deal for sotagliflozin, which is currently in development and undergoing Phase 3 trials. 

11/05/2015 - 5:41pm

As the company heads into the holiday season and Q4, CEO Jerry Shore said Fred’s is aiming to optimize its operations and finish the fiscal year with a strong financial showing. 

11/05/2015 - 1:34pm

Though Costco’s U.S. sales saw a 1% increase over both the four weeks and nine weeks ended Nov. 1 compared to last year, its Canadian stores saw an 8% decrease in comparable sales. 

11/03/2015 - 5:21pm

With the completion of this step all Mylan needs is word from Perrigo’s shareholders on whether or not they will accept the company’s $27 billion acquisition offer, which was tendered on Sept. 14. 

11/02/2015 - 1:53pm

First-quarter revenue for the Pharmaceutical segment increased 19% to $25.1 billion due to growth from existing and new customers and, to a lesser extent, contributions from acquisitions. 

11/02/2015 - 1:22pm

The New York Times is reporting that Irish pharmaceutical company Shire has entered into an agreement to purchase Dyax, a biotechnology company that makes treatements for hereditary angioedema (HAE), for as much as $6.5 billion. “This highly complementary transaction aligns with and accelerates our strategy to build a global leading biotechnology company focused on rare diseases and specialty conditions,” Shire’s CEO Dr. Flemming Ornskov said. “It adds to our portfolio of best-in-class therapies addressing unmet needs in our core therapeutic areas, expanding and extending our leadership position in HAE.” (New York Times)

11/02/2015 - 1:09pm

Publix sales for the first nine months of 2015 were $24.1 billion, a 6.4% increase. Comparable-store sales for the first nine months of 2015 increased 4.5%.

10/30/2015 - 12:56pm

"Competition is essential in every part of our economy, and especially so in a market as complex and important as health care," Sen. Mike Lee, R-Utah, said about Walgreens’ planned acquisition of Rite Aid.